Kelleni’s protocol incorporating non-steroidal anti-inflammatory drugs and nitazoxanide to early manage dengue virus disease: An antiviral silver bullet

doi:10.12998/wjcc.v13.i28.108181

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (288)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

183

Figures (1-2)

Sum=205

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=59

Publishing Process of This Article

Item

Count

Browse

Download

Sum=16

Oct 6, 2025 (publication date) through Aug 10, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Field of Vision

World J Clin Cases. Oct 6, 2025; 13(28): 108181
Published online Oct 6, 2025. doi: 10.12998/wjcc.v13.i28.108181

Open in New Tab Full Size Figure Download Figure

Figure 1 Early immune-modulation using Kelleni’s protocol aborts dengue fever progression. NSAID: Non-steroidal anti-inflammatory drugs.

Open in New Tab Full Size Figure Download Figure

Figure 2 Empiric use of Kelleni’s protocol to manage various viral infections. SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2; NSAID: Non-steroidal anti-inflammatory drugs.

Citation: Kelleni MT. Kelleni’s protocol incorporating non-steroidal anti-inflammatory drugs and nitazoxanide to early manage dengue virus disease: An antiviral silver bullet. World J Clin Cases 2025; 13(28): 108181
URL: https://www.wjgnet.com/2307-8960/full/v13/i28/108181.htm
DOI: https://dx.doi.org/10.12998/wjcc.v13.i28.108181